This is a valuable comment emphasizing the need of collaboration with cardiologists in order to deal with the treatment of patients taking new generations of anti-platelet agents after coronary surgery or stenting.
That aspirin in doses of 75 mg no longer should be considered a risk factor for bleeding during major surgery and therefore can be continued is in my mind a dangerous advice for patients planned for SWL. It was in a patient who had not stopped aspirin that I noticed the first large subcapsular hematoma in a lithotripter with small and sharp focus.
This is a valuable comment emphasizing the need of collaboration with cardiologists in order to deal with the treatment of patients taking new generations of anti-platelet agents after coronary surgery or stenting.
That aspirin in doses of 75 mg no longer should be considered a risk factor for bleeding during major surgery and therefore can be continued is in my mind a dangerous advice for patients planned for SWL. It was in a patient who had not stopped aspirin that I noticed the first large subcapsular hematoma in a lithotripter with small and sharp focus.
Comments 1
This is a valuable comment emphasizing the need of collaboration with cardiologists in order to deal with the treatment of patients taking new generations of anti-platelet agents after coronary surgery or stenting.
That aspirin in doses of 75 mg no longer should be considered a risk factor for bleeding during major surgery and therefore can be continued is in my mind a dangerous advice for patients planned for SWL. It was in a patient who had not stopped aspirin that I noticed the first large subcapsular hematoma in a lithotripter with small and sharp focus.